Suppr超能文献

葡萄牙医院高危发热性中性粒细胞减少症抗生素处方的差异

Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals.

作者信息

Freitas Marta, Andrade Paulo, Pinto Ricardo, Trigo Fernanda, Azevedo Ana, Almeida Francisco

机构信息

Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-039 Porto, Portugal.

Unidade de Prevenção e Controlo de Infeção e Resistências aos Antimicrobianos, Centro de Epidemiologia Hospitalar, Unidade Local de Saúde São João, 4200-319 Porto, Portugal.

出版信息

Antibiotics (Basel). 2024 Aug 30;13(9):822. doi: 10.3390/antibiotics13090822.

Abstract

INTRODUCTION

Febrile neutropenia (FN) is a potentially severe entity, particularly in hemato-oncologic patients who have higher incidence of colonization with multidrug-resistant bacteria. Discrepancies among guidelines contribute to divergence in antimicrobial practices. Our objective was to assess the variation of practices in antimicrobial therapy in high-risk FN among Portuguese hematologists.

METHODS

We conducted a cross-sectional study through the implementation of an online survey, open to all clinical hematologists in the country. To characterize practice patterns regarding critical elements in FN management, three clinical vignettes were designed to describe typical situations where narrow-spectrum empiric antibiotics (vignette 1), short-course therapy (vignette 2) and de-escalation (vignette 3) could be performed. The remaining questions characterized clinical experience, department size, and differentiation and decision-making process regarding FN antibiotic therapy.

RESULTS

The survey yielded 31 responses from 11 hospitals across four regions. All respondents opted for empiric narrow-spectrum antibiotics, 22.6% opted for short-course therapy (mostly senior specialists from larger settings) and 35.5% for de-escalation (mostly young specialists). Availability of an FN protocol seemed to favor both approaches. These findings should be complemented by qualitative assessments of barriers to best practices and should support the need for interventions to improve antibiotic use in febrile neutropenia.

摘要

引言

发热性中性粒细胞减少症(FN)是一种潜在的严重病症,在血液肿瘤患者中尤为如此,这些患者感染多重耐药菌的发生率较高。指南之间的差异导致抗菌治疗方法存在分歧。我们的目的是评估葡萄牙血液科医生在高危FN抗菌治疗中的实践差异。

方法

我们通过开展一项在线调查进行横断面研究,该调查面向该国所有临床血液科医生。为了描述FN管理关键要素的实践模式,设计了三个临床病例 vignette 来描述可使用窄谱经验性抗生素(病例 vignette 1)、短程治疗(病例 vignette 2)和降阶梯治疗(病例 vignette 3)的典型情况。其余问题涉及临床经验、科室规模以及FN抗生素治疗的鉴别和决策过程。

结果

该调查收到了来自四个地区11家医院的31份回复。所有受访者都选择了经验性窄谱抗生素,22.6%的受访者选择了短程治疗(大多是来自大型医疗机构的资深专家),35.5%的受访者选择了降阶梯治疗(大多是年轻专家)。FN治疗方案的可用性似乎对这两种方法都有利。这些发现应以对最佳实践障碍的定性评估作为补充,并应支持采取干预措施以改善发热性中性粒细胞减少症患者抗生素使用的必要性。

相似文献

1
Variation in Antibiotic Prescription in High-Risk Febrile Neutropenia in Portuguese Hospitals.
Antibiotics (Basel). 2024 Aug 30;13(9):822. doi: 10.3390/antibiotics13090822.
3
Characterization of Febrile Neutropenia Management in Children With Malignancies: A Single-Center Evaluation.
J Pediatr Pharmacol Ther. 2023;28(3):235-240. doi: 10.5863/1551-6776-28.3.235. Epub 2023 Jun 2.
4
Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
J Oncol Pharm Pract. 2016 Oct;22(5):696-701. doi: 10.1177/1078155215597558. Epub 2015 Jul 30.
5
Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.
J Paediatr Child Health. 2018 Jul;54(7):761-769. doi: 10.1111/jpc.13899. Epub 2018 Apr 14.
8
Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
Transplant Cell Ther. 2024 Oct;30(10):1031.e1-1031.e9. doi: 10.1016/j.jtct.2024.07.020. Epub 2024 Jul 27.
10
Antimicrobial stewardship in high-risk febrile neutropenia patients.
Antimicrob Resist Infect Control. 2022 Mar 26;11(1):52. doi: 10.1186/s13756-022-01084-0.

本文引用的文献

1
Behavioral Components and Context of Antimicrobial Prescription in a Tertiary Hospital in Portugal.
Antibiotics (Basel). 2023 Jun 8;12(6):1032. doi: 10.3390/antibiotics12061032.
5
Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey.
Bone Marrow Transplant. 2020 Aug;55(8):1588-1594. doi: 10.1038/s41409-020-0811-y. Epub 2020 Feb 11.
6
Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.
Cancer. 2020 Apr 1;126(7):1434-1447. doi: 10.1002/cncr.32641. Epub 2019 Dec 24.
8
A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period.
PLoS One. 2019 Oct 31;14(10):e0224299. doi: 10.1371/journal.pone.0224299. eCollection 2019.
9
Standardizing Febrile Neutropenia Management: Antimicrobial Stewardship in the Hematologic Malignancy Population.
J Oncol Pract. 2019 Sep;15(9):e843-e848. doi: 10.1200/JOP.18.00775. Epub 2019 Jul 19.
10
Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Cochrane Database Syst Rev. 2019 Jan 3;1(1):CD012184. doi: 10.1002/14651858.CD012184.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验